Alliance is a publicly owned international pharmaceutical company listed on AIM, part of the London Stock Exchange. We started trading in 1998 and have grown strongly to an annual turnover approaching £100 million. At the heart of our business sits a diverse team of dedicated, enthusiastic and experienced professionals who are committed to providing much needed medicines around the world. Our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients. We look carefully for certain criteria in these products and select for a blend of underlying sales stability and growth potential. More information can be found in Our Deal History. Capital intensive activities such as manufacturing, warehousing and logistics are outsourced to class leading specialists in these fields. We distribute our products through wholesalers, retail pharmacies, hospitals and a well-respected international network of distributors. Our modern offices are located in the market town of Chippenham, Wiltshire, 70 minutes from central London by direct train. We also have offices in Paris, Milan, Madrid, DÙsseldorf, Dublin, Shanghai and Singapore. Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)